TW201206418A - Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease - Google Patents

Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease Download PDF

Info

Publication number
TW201206418A
TW201206418A TW100123320A TW100123320A TW201206418A TW 201206418 A TW201206418 A TW 201206418A TW 100123320 A TW100123320 A TW 100123320A TW 100123320 A TW100123320 A TW 100123320A TW 201206418 A TW201206418 A TW 201206418A
Authority
TW
Taiwan
Prior art keywords
contact lens
panthenol
composition
eye
solution
Prior art date
Application number
TW100123320A
Other languages
English (en)
Chinese (zh)
Inventor
Brien Anthony Holden
Original Assignee
Holden Brien Vision Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010902954A external-priority patent/AU2010902954A0/en
Application filed by Holden Brien Vision Inst filed Critical Holden Brien Vision Inst
Publication of TW201206418A publication Critical patent/TW201206418A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW100123320A 2010-07-02 2011-07-01 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease TW201206418A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2010902954A AU2010902954A0 (en) 2010-07-02 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Publications (1)

Publication Number Publication Date
TW201206418A true TW201206418A (en) 2012-02-16

Family

ID=45401233

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100123320A TW201206418A (en) 2010-07-02 2011-07-01 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Country Status (9)

Country Link
US (2) US9161923B2 (https=)
EP (1) EP2588096A4 (https=)
JP (1) JP2013534527A (https=)
CN (1) CN103037858A (https=)
AU (1) AU2011274245B2 (https=)
CA (1) CA2803935A1 (https=)
SG (1) SG186782A1 (https=)
TW (1) TW201206418A (https=)
WO (1) WO2012000055A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
EP2588096A4 (en) * 2010-07-02 2013-12-25 Holden Brien Vision Inst COMPOSITION FOR THE PREVENTION AND TREATMENT OF CONTACT LENS-RELATED PAPILLAR TIN TREATMENT AND ALLERGIC EYE DISEASES
AR089518A1 (es) * 2012-12-27 2014-08-27 Vega Villavicencio Parsival Costra artificial porosa semipermeable
RS58731B1 (sr) * 2014-01-22 2019-06-28 Visufarma B V Kompozicija koja sadrži jota-karagenan protiv virusnog konjuktivitisa
NZ728487A (en) * 2014-08-08 2021-07-30 Shenzhen Hightide Biopharmaceutical Ltd Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
PL3072503T3 (pl) * 2015-03-26 2021-01-11 D.M.G. Italia Srl Kompozycja okulistyczna do ochrony rogówki
EP3496516B1 (en) 2017-12-11 2020-02-19 Ion Beam Applications S.A. Superconductor cyclotron regenerator
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3827818A1 (en) * 2019-11-26 2021-06-02 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition
WO2025253406A1 (en) * 2024-06-05 2025-12-11 Sentiss Pharma Private Limited Dexpanthenol gel forming solution and method of preparation thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9914813A (pt) * 1998-10-27 2001-07-03 Alcon Lab Inc Sistema conservante para composições farmacêuticas administráveis topicamente
US20070104744A1 (en) 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
AU2002228449B2 (en) * 2001-01-09 2007-12-06 Louis Johan Wagenaar Procedure and composition of treatment and/or care of the eye
TW586945B (en) * 2001-01-12 2004-05-11 Novartis Ag Lens care product containing dexpanthenol
DE10161110A1 (de) 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
US20050220742A1 (en) 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US20070243275A1 (en) 2006-04-13 2007-10-18 Gilbard Jeffrey P Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
WO2009094466A2 (en) * 2008-01-22 2009-07-30 University Of Florida Research Foundation, Inc. Contact lenses for extended release of bioactive agents containing diffusion attenuators
US20100087550A1 (en) 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
NL2002214C2 (en) * 2008-11-17 2010-05-18 Louis Johan Wagenaar Contact lens care solution.
CA2760591C (en) 2009-05-01 2018-01-02 Advanced Vision Research, Inc. Cleanser compositions and methods for using the same
IT1393712B1 (it) 2009-05-13 2012-05-08 Bruschettini Srl Composizioni oftalmiche per la riepitelizzazione, la cicatrizzazione, e la disinfezione dei tessuti oculari
EP2588096A4 (en) * 2010-07-02 2013-12-25 Holden Brien Vision Inst COMPOSITION FOR THE PREVENTION AND TREATMENT OF CONTACT LENS-RELATED PAPILLAR TIN TREATMENT AND ALLERGIC EYE DISEASES

Also Published As

Publication number Publication date
US20130102679A1 (en) 2013-04-25
EP2588096A4 (en) 2013-12-25
SG186782A1 (en) 2013-02-28
US9161923B2 (en) 2015-10-20
CN103037858A (zh) 2013-04-10
JP2013534527A (ja) 2013-09-05
CA2803935A1 (en) 2012-01-05
EP2588096A1 (en) 2013-05-08
AU2011274245B2 (en) 2014-07-17
AU2011274245A1 (en) 2013-01-10
WO2012000055A1 (en) 2012-01-05
US20160074345A1 (en) 2016-03-17

Similar Documents

Publication Publication Date Title
TW201206418A (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
JP7432654B2 (ja) 人工涙液、コンタクトレンズ及び薬剤担体組成物並びにその使用方法
JP7329019B2 (ja) 老視を治療するための組成物及び方法
JP5877885B2 (ja) 防腐剤を含まない非粘性プロスタグランジン系点眼液用のポリマー送達システム
CN102811610B (zh) 无刺激性眼科聚维酮碘组合物
TWI650122B (zh) 用於預防及／或治療乾眼症之組成物、方法及／或裝置
US20090010850A1 (en) Formulations and methods for treating dry eye
US20070297981A1 (en) Formulations and methods for treating dry eye
WO2010141831A1 (en) Ophthalmic formulations, methods of manufacture, and methods of using same
JP2011503061A (ja) 浸透圧活性剤及び血管収縮剤を含む眼けん腫脹の治療及び防止のための組成物
MX2011009802A (es) Formulaciones oftalmicas de cetirizina y metodos de uso.
AU2013256144A1 (en) Ophthalmic compositions with improved dessication protection and retention
CN113227304A (zh) 人工泪液、隐形眼镜和药物载体组合物及其使用方法
JP2025159201A (ja) 眼科組成物
EP2379078A2 (en) Topical formulations of flap inhibitors for administration to an eye
JP2010526085A (ja) 抗炎症化合物によるｎ−ハロゲン化アミノ酸処方物
JP2017119669A (ja) 異物感改善用眼科組成物
CN104994839A (zh) 局部眼用镇痛剂
HK1182338A (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
CN116270442A (zh) 一种用于矫正近距离视力的眼用制剂